NCT07578376 Empowered Relief® for Cancer Survivors With Chronic Pain
| NCT ID | NCT07578376 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Chronic Pain Due to Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 215 participants |
| Start Date | 2026-06 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 215 participants in total. It began in 2026-06 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participants in the control condition will be invited to attend ER class after the 3-month observation period.
Eligibility Criteria
Inclusion Criteria: History of cancer diagnosis, completion of active cancer treatment, cancer free at the time of enrollment, experience of body pain most or every day, pain duration at least 3 months, and English fluency. Exclusion Criteria: Significant psychological and cognitive impairment that limits one's ability to complete study tasks (completion of online survey, attending the zoom-based ER class). Life-threatening acute illness (e.g., infection, heart attack, injury), and no access to a computer, a smartphone or a tablet.
Contact & Investigator
Sophia You, PhD, ABPP
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT07578376 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Chronic Pain Due to Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07578376 currently recruiting?
Yes, NCT07578376 is actively recruiting participants. Contact the research team at Dokyoung-You@ou.edu for enrollment information.
Where is the NCT07578376 trial being conducted?
This trial is being conducted at Tulsa, United States.
Who is sponsoring the NCT07578376 clinical trial?
NCT07578376 is sponsored by University of Oklahoma. The principal investigator is Sophia You, PhD, ABPP at University of Oklahoma. The trial plans to enroll 215 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.